COMPANY
Kedrion Biopharma
FDA-approved therapeutic company
Timeline
- FDA FDA New drug/biologic (novel): QIVIGY (immune globulin intravenous, human-kthm, 10% solution) — BLA125822, Sep 26, 2025. Applicant at approval: Kedrion S.p.A.. source ↗
FDA records (last 2 years)
- FDA New drug/biologic (novel): QIVIGY (immune globulin intravenous, human-kthm, 10% solution) — BLA125822, Sep 26, 2025. Applicant at approval: Kedrion S.p.A.. source ↗
Connect
See your connections at Kedrion Biopharma on LinkedIn (search by name, results not checked)